Evidence map›Paper›PMID 30690091›Full record

ArticleInternational journal for parasitology2019

The rational simplification of a recombinant cocktail vaccine to control the parasitic nematode Teladorsagia circumcincta.

Alasdair J Nisbet, Tom N McNeilly, Daniel R G Price, E Margaret Oliver, Yvonne Bartley, Mairi Mitchell, Javier Palarea-Albaladejo, Jacqueline B Matthews

Open access · hybridAbstract read
In one paragraph

Article in International journal for parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cocktail vaccine for the management ofFrontiers in immunology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Immunization With RecombinantFrontiers in veterinary science · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Helminth Vaccines in Ruminants: From Development to Application.The Veterinary clinics of North America. Food animal practice · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alasdair J NisbetMoredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, United Kingdom. Electronic address: Alasdair.Nisbet@moredun.ac.uk.
Tom N McNeillyMoredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, United Kingdom.
Daniel R G PriceMoredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, United Kingdom.
E Margaret OliverMoredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, United Kingdom.
Yvonne BartleyMoredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, United Kingdom.
Mairi MitchellMoredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, United Kingdom.
Javier Palarea-AlbaladejoBiomathematics & Statistics Scotland, JCMB, The King's Buildings, Edinburgh EH9 3FD, United Kingdom.
Jacqueline B MatthewsMoredun Research Institute, Pentlands Science Park, Edinburgh EH26 0PZ, United Kingdom.
Moredun Research Institute · GBBiomathematics and Statistics Scotland · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L027186/1
6 · The paper itself

Abstract

Using data from five independent vaccine trials, which employed a subunit cocktail vaccine containing eight recombinant proteins to protect sheep against Teladorsagia circumcincta, a strategy was developed to simplify antigen complexity of the vaccine. A meta-analysis of data from these five trials demonstrated statistically significant reductions in cumulative faecal egg count and worm burden in vaccinated sheep when compared with those which had received adjuvant only (P = 0.009 and P < 0.0001, respectively). Relationships between antigen-specific antibody levels, antibody avidity and parasitological parameters of efficacy were analysed for each of the eight proteins in these trials. Of these, the strongest correlations between percentage reduction in cumulative faecal egg count and avidity were obtained for the vaccine antigen T. circumcincta apyrase-1 (Tci-APY-1) in relation to either total antigen-specific IgG or IgG1 in sera (P = 0.019 and P = 0.030, respectively). In addition, IgG and IgA within the serum and abomasal mucus of control (parasite challenged) lambs strongly recognised Tci-APY-1 and T. circumcincta metalloproteinase-1 (Tci-MEP-1) but only weakly bound the other six antigens, indicating Tci-APY-1 and Tci-MEP-1 are most effectively recognised by the parasite-induced antibody response. On the basis of these findings, a two-protein vaccine comprising Tci-APY-1 and Tci-MEP-1 was tested in a direct comparison with the original eight-component vaccine. A further group was immunised with Tci-MEP-1 in combination with a mutated form of Tci-APY-1 (mTci-APY-1), which had no enzymatic activity. Across the trial, the mean faecal egg count levels of the eight-antigen recipients were lower than those of the adjuvant only control group (P = 0.013) and the mean FEC of the mTci-APY-1 and Tci-MEP-1 recipients was lower, although not statistically significantly, than that of the adjuvant-only control group (P = 0.093). Mean cumulative faecal egg count levels were reduced by 43% in lambs immunised with mTci-APY-1 plus Tci-MEP-1 compared with the controls (P = 0.079).

Indexed as

AbomasumAnimalsAntibodies, HelminthAntibody AffinityAntigens, HelminthFecesImmunoglobulin AImmunoglobulin GParasite Egg CountSheepSheep DiseasesTreatment OutcomeTrichostrongyloideaTrichostrongyloidiasisVaccines, SubunitVaccines, SyntheticAntibodies, HelminthAntigens, HelminthImmunoglobulin AImmunoglobulin GVaccines, SubunitVaccines, SyntheticApyraseMetalloproteinaseNematodesTeladorsagiaVaccination

Identifiers

PMID30690091
PMCPMC6456928
OpenAlexW2912262043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.